A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Servier
AstraZeneca
Hoffmann-La Roche
Pfizer
Avistone Biotechnology Co., Ltd.
IDEAYA Biosciences
Bayer
Eli Lilly and Company
Hummingbird Bioscience
BioNTech SE
Astellas Pharma Inc
Novartis
Bristol-Myers Squibb
Janssen Research & Development, LLC
7 Hills Pharma, LLC
Janssen Research & Development, LLC
Tango Therapeutics, Inc.
Bristol-Myers Squibb
Janssen Research & Development, LLC
Genmab
Hoffmann-La Roche
Genmab
DualityBio Inc.
Turning Point Therapeutics, Inc.
Servier
Servier
BeOne Medicines
Therapex Co., Ltd
EMD Serono
Novartis
Astellas Pharma Inc
Amgen
Aulos Bioscience, Inc.
AstraZeneca
Revolution Medicines, Inc.
Obsidian Therapeutics, Inc.
Radiopharm Theranostics, Ltd
3D Medicines
AstraZeneca
Regeneron Pharmaceuticals
Hoffmann-La Roche
Dragonfly Therapeutics
Pfizer
Novartis
Synthekine
Frontier Medicines Corporation
Bristol-Myers Squibb
AstraZeneca
Merck Sharp & Dohme LLC